[Selection of IOL power formula for patients with cataract and high myopia].

OBJECTIVE: To compare the accuracy of two IOL power formulas (SRK-T and SRK-II) in order to improve the accuracy of predicative IOL powers for patients with cataract and high myopia. METHODS: (1) Patient's axial lengths of the eye, K-readings and A-constants were input to the SRK-T and SRK-II formulas. The differences in predicative refraction between the two formulas were compared. (2) Eight six patients (130 eyes) with cataract and high myopia underwent phacoemulsification and posterior chamber IOL implantation were studied. These patients were randomly divided into two groups and received IOL whose power was determined by either SRK-T or SRK-II. Three months after IOL implantation, the postoperative refractions were recorded and compared with predictive refractions. Patients were followed-up for 3 to 24 months. RESULTS: (1) When K-reading was 43.00 D, there was no statistically significant difference between the results from these two formulas (P > 0.05) and there was no correlation between the difference and the axial lengths (P > 0.05). In eyes with K-reading at 39.00 D, 41.00 D, 45.00 D, or 47.00 D, there was statistically significant difference between the results from these two formulas (P < 0.05). The difference between the two formulas was in proportional to the axial length (P < 0.05). (2) The mean error between the postoperative refraction and predictive refraction determined by SRK-T and SRK-II formula was 0.08 D and -0.79 D, respectively. The difference between these two formulas was statistically significant (P < 0.05). CONCLUSION: Selection of IOL power formula should consider the axial length, K-reading and other related factors. SRK-T formula is appropriate for high myopia eyes with axial length longer than 26.0 mm. In this group, SRK-T formula is much more accurate than the SRK-II formula.

[Clinical research of the implantation of phakic anterior chamber intraocular lens for high myopia].

OBJECTIVE: To investigate the efficacy and safety of the implantation of phakic anterior chamber intraocular lens (IOL) for high myopia. METHODS: A consecutive group of 73 eyes in 41 patients with -7.00 to -30.00 diopters (D) of myopia were implanted. RESULTS: All of 73 eyes were implanted successfully and have been followed-up for 3 m (months). The uncorrected visual acuity was from FC/33 cm to 0.2 pre-operatively and 0.1 to 1.0 3 m post-operatively. The best corrected visual acuity (BCVA) was from 0.05 to 1.0 pre-operatively and 0.1 to 1.0 3 m post-operatively. The post-operative BCVA of every eye was not worse than the pre-operative one. The refractive diopters were from -7.00 to -30.00 D pre-operatively and -6.00 to +2.50 D 3 m post-operatively. There were no significant differences between pre- and 3 m post-operative mean corneal astigmatism (t = 1.751, P = 0.082) and mean intraocular pressure (IOP) (t = 1.181, P = 0.240), respectively. The mean counts of endothelial cells was (2 680 +/- 538)/mm(2) pre-operatively and (2 514 +/- 420)/mm(2) 3 m post-operatively. There was no significant difference (t = 1.182, P = 0.242) though it decreased 6.19%. No severe complications occurred. CONCLUSIONS: The implantation of phakic anterior chamber IOL for high myopia is predictable, reversible and controllable with simple manipulation. No severe complication occurred in 3 m post-operatively, and long-time follow-up is still required.

[Expression of autophagy-related genes Beclin1 and MAPLC3 in non-small cell lung cancer].

BACKGROUND & OBJECTIVE: Some studies have indicated that the down-regulation of autophagy-related genes might result in tumorigenesis. This study was to investigate the expression and significance of autophagy-related genes Beclin1 and microtubule-associated protein 1 light chain 3 (MAPLC3) in human non-small cell lung cancer (NSCLC). METHODS: The expression of Beclin1 and MAPLC3 in tumor tissues, adjacent non-cancerous tissues, and normal tissues from 72 specimens of NSCLC were detected by immunofluorescence staining, Western blot, and reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: The positive rates of Beclin1 and MAPLC3 were significantly lower in NSCLC tissues than in adjacent non-cancerous tissues and normal tissues (8.3% vs. 100% and 100% for Beclin1, chi2=199.40, P<0.01; 13.9% vs. 100% and 100%for MAPLC3, chi2=182.75, P<0.01). The mRNA levels of Beclin1 and MAPLC3 were significantly lower in NSCLC tissues than in adjacent non-cancerous tissues and normal tissues (1.30+/- 0.44 vs. 1.69+/-0.59 and 1.67+/-0.48 for Beclin1, F=6.6, P<0.01; 4.55+/-1.23 vs. 6.73+/-1.31 and 6.90+/-1.87 for MAPLC3, F=14.1, P<0.01). The protein levels of Beclin1 and MAPLC3 were significantly lower in NSCLC tissues than in adjacent non-cancerous tissues and normal tissues (3.49+/-0.72 vs. 5.31+/-1.16 and 6.33+/-1.58 for Beclin1, F=9.73, P<0.01; 2.43+/-0.35 vs. 3.12+/-0.73 and 3.41+/-0.90 for MAPLC3, F=3.22, P=0.04). CONCLUSION: The expression of autophagy-related genes are down-regulated in NSCLC, which may relate to tumorigenesis and development of lung cancer.